umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Favorable therapeutic responses in newly diagnosed CML-CP patients induced by Dasatinib are reflected at the CD34+CD38+Progenitor cell but not at the CD34+CD38-Stem cell level: Results from randomized NordCML006 study
Show others and affiliations
2011 (English)In: 53rd ASH Annual Meeting and Exposition, December 10-13, 2011: Program: Oral and Poster AbstractsType: OralSession: 632. Chronic Myeloid Leukemia - Therapy: Prediction of Response Monday, December 12, 2011: 4:30 PM Ballroom 20BC (San Diego Convention Center), American Society of Hematology , 2011, Vol. 118, no 21Conference paper, Published paper (Refereed)
Place, publisher, year, edition, pages
American Society of Hematology , 2011. Vol. 118, no 21
National Category
Hematology
Identifiers
URN: urn:nbn:se:umu:diva-53139ISI: 000299597101055OAI: oai:DiVA.org:umu-53139DiVA: diva2:510035
Conference
53rd ASH Annual Meeting and Exposition, December 10-13, 2011
Available from: 2012-03-14 Created: 2012-03-13 Last updated: 2012-03-14Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Markevärn, Berit
By organisation
Oncology
Hematology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 53 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf